USE OF INHALED CORTICOSTEROIDS IN PEDIATRIC ASTHMA: THE ROLE OF PHARMACEUTICAL CARE IN TREATMENT ADHERENCE AND SAFETY

Authors

  • Letycia Lucena Alves Centro universitário Santa Maria
  • Carla Islene de Holanda Moreira Centro Universitário Santa Maria - UNIFSM
  • Anuska Rhévia Lacerda Pontes Centro Universitário Santa Maria - UNIFSM
  • José Guilherme Ferreira Marques Galvão Centro Universitário Santa Maria - UNIFSM

DOI:

https://doi.org/10.61164/jjaqav20

Keywords:

Asma, pediátrico, atenção farmacêutica, farmacêutica

Abstract

Asthma is a common chronic disease in childhood, characterized by persistent airway inflammation and recurrent episodes of dyspnea, wheezing, and coughing. Maintenance treatment with inhaled corticosteroids (ICS) is considered the first choice for controlling persistent asthma in children, due to its effectiveness in reducing exacerbations and improving lung function. However, adherence to treatment remains a challenge, especially during asymptomatic periods. Objective: This study aims to evaluate the safety and adherence to the use of ICS in the pediatric population, highlighting the pharmacist's role in clinical care. Method: This is an integrative literature review, based on published studies obtained from databases such as PubMed and SciELO. Data analysis showed that pharmaceutical interventions, including health education, correction of inhalation technique, and continuous monitoring, contribute to greater adherence to treatment and safety in the use of medications. Expected Results: The results point to the fundamental role of the pharmacist in promoting the rational use of ICS and improving the quality of life of asthmatic children.

Downloads

Download data is not yet available.

References

FERRANTE G.; LA GRUTTA S. The Burden of Pediatric Asthma. Front Pediatr, 2018 Jun 22;6:186. doi: 10.3389/fped.2018.00186. PMID: 29988370; PMCID: PMC6023992. DOI: https://doi.org/10.3389/fped.2018.00186

FULLER J.M.; SAINI B.; BOSNIC-ANTICEVICH S.; GARCIA C. V.; BENRIMOJ S.I.; ARMOUR C. Testing evidence routine practice: Using an implementation framework to embed a clinically proven asthma service in Australian community pharmacy. Res Social Adm Pharm. 2017 Sep-Oct;13(5):989-996. doi: 10.1016/j.sapharm.2017.05.019. Epub 2017 May 30. PMID: 28583300. DOI: https://doi.org/10.1016/j.sapharm.2017.05.019

GOMES L. S.; OLIVEIRA P. M. R.; REIS C. G.; CARDOSO T. C.; XAVIER G. M.; ARAÚJO V. A.; GOMES A. C. S.; MOTA H. S. As consequências do uso prolongado de corticosteroides inalatórios em crianças com asma. Revista Eletrônica Acervo Saúde, p7, Nov. 2022. DOI: https://doi.org/10.25248/reas.e11282.2022

MATSUNAGA N.Y; RIBEIRO M.A.; SAAD I.A.; MORCILLO A.M.; RIBEIRO J.D.; TORO A.A. Evaluation of quality of life according to asthma control and asthma severity in children and adolescents. J Bras Pneumol, 2015 Nov-Dec;41(6):502-8. doi: 10.1590/S1806-37562015000000186. PMID: 26785958; PMCID: PMC4723001. DOI: https://doi.org/10.1590/s1806-37562015000000186

NÚCLEO DE TELESSAÚDE SANTA CATARINA. Qual a segurança no uso de corticoides inalatórios na pediatria? BVS Atenção Primária em Saúde, 21 set. 2015.

ORRIËNS L.B.; VIJVERBERG S.J.H.; MAITLAND-VAN DER ZEE A.H.; LONGO C. Nonadherence to inhaled corticosteroids: A characteristic of the pediatric obese-asthma phenotype? Pediatr Pulmonol, 2021 May;56(5):948-956. doi: 10.1002/ppul.25253. Epub 2021 Jan 12. PMID: 33434419. DOI: https://doi.org/10.1002/ppul.25253

PANERARI, J.; & GALENDE, S.B. CORTICOSTERÓIDES UTILIZADOS NO TRATAMENTO DA ASMA BRÔNQUICA. Revisão Uningá, v24, n1, 2015. Obtido em https://revista.uninga.br/uningareviews/article/view/1676.

PIZZICHINI, M. M. M.; CARVALHO-PINTO, R. M.; CANÇADO J. E. D.; RUBIN, A. S.; NETO, A. C.; CARDOSO A. P.; CRUZ A. A.; FERNANDES, A. L. G.; BLANCO, D. C.; VIANNA, E. O.; JUNIOR, G. C.; RIZZO, J. A.; FRITSCHER, L. G.; CAETANO, L.B.;

PEREIRA, L. F. F.; RABAHI, M. F.; OLIVEIRA, M. A.; LIMA, M. A.; ALMEIDA, M. B.; STELMACH, R.; PITREZ, P. M.; CUKIER, A. 2020 Brazilian Thoracic Association recommendations for the management of asthma. Jornal brasileiro de pneumologia: publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, v. 46, n. 1, p. e20190307, 2020. DOI: https://doi.org/10.1590/1806-3713/e20190307

SOCIEDADE BRASILEIRA DE PNEUMOLOGIA E TISIOLOGIA. Apenas 12,3% dos asmáticos brasileiros estão com a doença bem controlada. Brasília, 2023.

ANTHONY, L.; AXTELL, S.; NIXON, B. Improvements in Asthma Control After Pharmacist Involvement in an Outpatient Pediatric Asthma Clinic. Journal of Pharmacy Practice, 14 fev. 2025. DOI: https://doi.org/10.1177/08971900251320740

HAYES, B. et al. Dangers of under‐treatment and over‐treatment with inhaled corticosteroids in children with asthma. Pediatric Pulmonology, v. 60, n. 1, 8 nov. 2024. DOI: https://doi.org/10.1002/ppul.27327

JONES, H.; LAWTON, A.; GUPTA, A. Asthma Attacks in Children—Challenges and Opportunities. Indian Journal of Pediatrics, v. 89, n. 4, p. 373–377, 21 jan. 2022. DOI: https://doi.org/10.1007/s12098-021-04069-w

KASSA, E.; KEBEDE, R. A.; HABTE, B. M. Perceptions towards childhood asthma and barriers to its management among patients, caregivers and healthcare providers: a qualitative study from Ethiopia. BMC Pulmonary Medicine, v. 22, n. 1, 8 maio 2022. DOI: https://doi.org/10.1186/s12890-022-01984-2

LIN, G. et al. Exploring the knowledge, attitude, and practice of community pharmacists regarding pediatric asthma management in Guangdong Province, China: a cross-sectional survey study. BMC Medical Education, v. 25, n. 1, p. 291–291, 22 fev. 2025. DOI: https://doi.org/10.1186/s12909-025-06885-6

PEARCE, C. J. et al. Features of successful interventions to improve adherence to inhaled corticosteroids in children with asthma: A narrative systematic review. Pediatric Pulmonology, v. 57, n. 4, p. 822–847, 21 fev. 2022. DOI: https://doi.org/10.1002/ppul.25838

SHDAIFAT, M. B. M.; KHASAWNEH, R. A.; ALEFAN, Q. Clinical and economic impact of telemedicine in the management of pediatric asthma in Jordan: a pharmacist-led intervention. Journal of Asthma, v. 59, n. 7, p. 1452–1462, 8 maio 2021. DOI: https://doi.org/10.1080/02770903.2021.1924774

STEMPEL, D. A. Use of Systemic Corticosteroids in Children with Asthma: Evidence of Treatment of Failure and Future Risk. The Journal of Allergy and Clinical Immunology In Practice, v. 9, n. 4, p. 1552–1553, 1 abr. 2021. DOI: https://doi.org/10.1016/j.jaip.2021.01.002

TAKKINSATIAN, MD, P. et al. Psychosocial factors and lack of asthma knowledge undermine child and adolescent adherence to inhaled corticosteroid. Journal of Asthma, v. 59, n. 11, p. 1–12, 1 dez. 2021. DOI: https://doi.org/10.1080/02770903.2021.1999468

VOLERMAN, A. et al. Strategies for Improving Inhalation Technique in Children: a Narrative Review. Patient Preference and Adherence, v. Volume 15, n. 1, p. 665–675, mar. 2021. DOI: https://doi.org/10.2147/PPA.S267053

Published

2025-12-15

How to Cite

USE OF INHALED CORTICOSTEROIDS IN PEDIATRIC ASTHMA: THE ROLE OF PHARMACEUTICAL CARE IN TREATMENT ADHERENCE AND SAFETY. (2025). Revista Multidisciplinar Do Nordeste Mineiro, 21(03), 1-13. https://doi.org/10.61164/jjaqav20